Evaluation of anti-prion activity of congo red and its derivatives in experimentally infected hamsters.

Autor: Poli G; Dipartimento di Patologia Animale, Igiene e Sanità Pubblica Veterinaria, Facoltà di Medicina Veterinaria, Università di Milano, Milan, Italy. giorgio.poli@unimi.it, Martino PA, Villa S, Carcassola G, Giannino ML, Dall'Ara P, Pollera C, Iussich S, Tranquillo VM, Bareggi S, Mantegazza P, Ponti W
Jazyk: angličtina
Zdroj: Arzneimittel-Forschung [Arzneimittelforschung] 2004; Vol. 54 (7), pp. 406-15.
DOI: 10.1055/s-0031-1296992
Abstrakt: Among transmissible spongiform encephalopathies (TSE), particularly dreadful are the bovine spongiform encephalopathy (BSE), because of its epidemic character, and the new variant of Creutzfeldt-lakob disease (vCJD) in man, possibly related to BSE prion, through the intake of infected food. To treat TSE, many potentially therapeutic agents have been tested: some of them, among which is Congo Red (CAS 573-58-0, CR), delayed the onset of symptoms in scrapie-infected rodents, and some CR derivatives proved to be effective in vitro. The capacity of a synthesized CR derivative (CR-A) and of the aromatic central benzidine rings of CR (CR-B) to abrogate scrapie-induced disease in experimentally infected hamsters was assayed. CR, used as reference substance, administered i.c. after pre-incubation with the scrapie inoculum, was strongly effective in slowing the progression of the infection, while both CR-A and CR-B, administered alone or together, were not effective. Both CR-A and CR, when administered by subcutaneous route in i.c. scrapie-infected animals. prolonged the survival time in comparison to controls; CR-B was not effective. Moreover, both CR and CR-A were very effective in prolonging the survival time of i.p. scrapie-infected hamsters. The hypothesis of possible different mechanisms of interaction between CR or CR-A and the scrapie agent related to the chemical structures of the molecules is discussed.
Databáze: MEDLINE